Printer Friendly

Detecting Clostridium botulinum.

To the Editor: In the October 2005 issue of Emerging Infectious Diseases, Song et al. described a fiber-optic, microsphere-based, high-density array composed of 18 species-specific probe microsensors, used to identify biological warfare agents, including Clostridium botulinum (1). Although the researchers used multiple probes for C. botulinum, we doubt that this approach is suitable for this organism.

C. botulinum comprises a heterogenous group of subspecies that produce botulinum neurotoxin (BoNT); identification and characterization usually rely on animal testing that focuses on antigenetically distinct toxins (2). Although strains of C. botulinum that do not produce toxins are sometimes isolated from wound infections not related to botulism, some strains of C. butyricum and C. baratii are also able to produce BoNTs.

The mouse bioassay is currently the accepted method for detecting BoNT. In this assay, mice that receive an intraperitoneal injection containing a sample with more than a minimum lethal dose show symptoms of botulinum intoxication and die. ELISAs, which recognize protein antigenic sites, are still less sensitive than the mouse bioassay (3).

Because the mouse bioassay requires euthanizing many animals, and results are not available for several hours, new diagnostic methods are needed. For C. botulinum, an organism widely dispersed in the environment, DNA-based methods may not provide the ultimate solution. Rapid methods to detect and differentiate active BoNTs, such as the rapid, mass spectrometry-based, functional method, are promising candidates to substitute for animal testing in the near future (4).

References

(1.) Song L, Ahn S, Walt DR. Detecting biological warfare agents. Emerg Infect Dis. 2005;11:1629-32.

(2.) Grif K, Dierich MP, Much P, Hofer E, Allerberger F. Identifying and subtyping species of dangerous pathogens by automated ribotyping. Diagn Microbiol Infect Dis. 2003;47:313-20.

(3.) Ferreira JL, Eliasberg SJ, Edmonds P, Harrison MA. Comparison of the mouse bioassay and enzyme-linked immunosorbent assay procedures for the detection of type A botulinal toxin in food. J Food Prot. 2004;67:203-6.

(4.) BaIT JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, et al. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis. 2005;11:1578-83.

Address for correspondence: Franz Allerberger, Medical University Innsbruck, Department of Hygiene, Fritz Pregl Str 3, Innsbruck Austria 6020; email: Franz. Allerberger@i-med.ac.at

Josef Karner * and Franz Allerberger *

* Medical University Innsbruck, Innsbruck, Austria
COPYRIGHT 2006 U.S. National Center for Infectious Diseases
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 
Article Details
Printer friendly Cite/link Email Feedback
Author:Allerberger, Franz
Publication:Emerging Infectious Diseases
Article Type:Letter to the editor
Date:Aug 1, 2006
Words:382
Previous Article:Nonsteroidal antiinflammatory drugs and group A streptococcal infection.
Next Article:Echinococcus multilocularis in dogs, Japan.


Related Articles
Making wetlands safe from avian botulism.
Invisible Death.
Purify, genetically characterize bacteriocin for C. botulinum.
Anthrax: facts, not fear. (Special Report).
BOTULISM ATTACKING DRUG USERS\Rare form of disease festers in punctures.
Unforgettable foods: what's more likely to make you sick. (Special Feature).
Botulism--information from the world health organization. (Technical Briefs).
Foodborne botulism in the United States, 1990-2000.
Botulinum neurotoxin detection and differentiation by mass spectrometry.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters